Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Jones

Showing results (201-210 of 281) with videos related to

Pageof 29
Sort By:
Biochemistry|March 16, 2005
Ligand, cofactor, and residue vibrations in the catalytic site of endothelial nitric oxide synthaseW John Ingledew, Susan M E Smith, Y T Gao, et al.
Blood|November 1, 1987
Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantationR J Jones, M Zuehlsdorf, S D Rowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplantC B Miller, S Piantadosi, G B Vogelsang, et al.
Lupus|October 1, 2016
Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantationD E Gladstone, M Petri, J Bolaños-Meade, et al.
Transplantation Proceedings|February 1, 1997
CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidityS J Noga, G B Vogelsang, A Seber, et al.
Circulation|June 1, 1987
Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart AssociationS M Grundy, P Greenland, A Herd, et al.
Blood|November 15, 1992
Impaired erythropoietin response to anemia after bone marrow transplantationC B Miller, R J Jones, M L Zahurak, et al.
British Journal of Cancer|October 9, 2015
A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year resultsT Eisen, A-B Loembé, Y Shparyk, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 4, 2022
Cancer Trial Impact: Understanding Implementation of the Short Course Oncology Treatment (SCOT) Trial Findings in colorectal cancer at a National LevelC R Hanna, E Lemmon, P S Hall, et al.
Blood|June 1, 1992
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemiaA M Yeager, G B Vogelsang, R J Jones, et al.
Pageof 29

Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
Biochemistry|March 16, 2005
Ligand, cofactor, and residue vibrations in the catalytic site of endothelial nitric oxide synthaseW John Ingledew, Susan M E Smith, Y T Gao, et al.
Blood|November 1, 1987
Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantationR J Jones, M Zuehlsdorf, S D Rowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplantC B Miller, S Piantadosi, G B Vogelsang, et al.
Lupus|October 1, 2016
Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantationD E Gladstone, M Petri, J Bolaños-Meade, et al.
Transplantation Proceedings|February 1, 1997
CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidityS J Noga, G B Vogelsang, A Seber, et al.
Circulation|June 1, 1987
Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart AssociationS M Grundy, P Greenland, A Herd, et al.
Blood|November 15, 1992
Impaired erythropoietin response to anemia after bone marrow transplantationC B Miller, R J Jones, M L Zahurak, et al.
British Journal of Cancer|October 9, 2015
A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year resultsT Eisen, A-B Loembé, Y Shparyk, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 4, 2022
Cancer Trial Impact: Understanding Implementation of the Short Course Oncology Treatment (SCOT) Trial Findings in colorectal cancer at a National LevelC R Hanna, E Lemmon, P S Hall, et al.
Blood|June 1, 1992
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemiaA M Yeager, G B Vogelsang, R J Jones, et al.
Pageof 29